External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Oncology AMCP Nexus 2024
Roche and Genentech at

AMCP Nexus 2024

October 14 - October 17
Las Vegas, USA
amcpnexus.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features
Personalised Healthcare
Oct 15 / Roche and Genentech
Comparison of Healthcare Resource Utilization and Costs in Patients With Spinal Muscular Atrophy (SMA) Treated With Risdiplam▼ or Nusinersen
Limited data on healthcare costs and HRU for individuals with SMA treated with DMTs exist. This retrospective cohort study used administrative claims data to compare real-world HRU and total costs among individuals with SMA treated with risdiplam▼ or nusinersen monotherapy in the US.
Neuroscience Spinal Muscular Atrophy Real World Data - Real World Evidence AMCP-NEXUS-2024

Sign up or login to unlock the full suite of MEDICALLY features
Oct 15 / Roche and Genentech
Real-World Treatment Patterns Among Patients With Paroxysmal Nocturnal Hemoglobinuria Initiating Eculizumab and Ravulizumab: A US Claims Analysis
C5 inhibitors are standard of care for PNH treatment in the US, with intravenous eculizumab and ravulizumab having transformed clinical outcomes. To ensure optimal care for patients given the recent FDA approvals of newer complement inhibitors, this poster reports results from a US claims analysis on real-world treatment patterns in patients with PNH who initiated eculizumab or ravulizumab.
Haematology Atypical Haemolytic Uraemic Syndrome AMCP-NEXUS-2024

Sign up or login to unlock the full suite of MEDICALLY features
Oct 15 / Roche and Genentech
Impact of Step-Therapy Policies on Clinical Outcomes and Healthcare Resource Utilization Among Medicaid Beneficiaries Living With Multiple Sclerosis (MS)
This study used Medicaid claims to understand the impact of step-therapy policies on outcomes for people with multiple sclerosis including time to first relapse and healthcare resource utilization.
Neuroscience Multiple Sclerosis AMCP-NEXUS-2024
12:00 AM
Duration 90mins Las Vegas, USA
Real-World Treatment Patterns Among Patients With Paroxysmal Nocturnal Hemoglobinuria Initiating Eculizumab and Ravulizumab: A US Claims Analysis
Chia-Wei Lin
Haematology | Atypical hemolytic uremic syndrome

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 90mins Las Vegas, USA
TRENDS IN COMMERCIAL HEALTH PLAN COSTS AND PATIENT LIABILITY IN STATES WITH OR CONSIDERING PRESCRIPTION DRUG AFFORDABILITY BOARDS
Danny Sheinson
Oncology - HealthTech

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 90mins Las Vegas, USA
REAL-WORLD COSTS ASSOCIATED WITH UPFRONT BIOMARKER TESTING IN ADVANCED NON-SMALL CELL LUNG CANCER AND METASTATIC COLORECTAL CANCER
Tu My To
Oncology - HealthTech

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 90mins Las Vegas, USA
IMPACT OF COPAY MAXIMIZER PROGRAMS ON TOTAL PATIENT LIABILITY
William Wong
Oncology - HealthTech

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 90mins Las Vegas, USA
Comparison of Healthcare Resource Utilization and Costs in Patients With Spinal Muscular Atrophy (SMA) Treated With Risdiplam▼ or Nusinersen
S Shapouri, D Lebovitch, Y Liu, TL Dickendesher, TM To
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 90mins Las Vegas, USA
Clinical Outcomes Among Risdiplam▼-Treated Patients With Spinal Muscular Atrophy (SMA) in the Cure SMA Clinical Data Registry
S Shapouri, TM To, S Whitmire, L Belter, M Schroth, TL Dickendesher, R Schuldt
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 90mins Las Vegas, USA
Building up social determinants of health data over time and space for linkage with real-world data and health equity enrichment
C Ng, P Zhang, S Kowal
HealthTech

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 90mins Las Vegas, USA
Impact of Step-Therapy Policies on Clinical Outcomes and Healthcare Resource Utilization Among Medicaid Beneficiaries Living With Multiple Sclerosis (MS)
Elmor D Pineda, Caroline Geiger, Elyse Swallow, Emily Gao, Ali Greatsinger, Manasi Mohan, Kirthana Sarathy, Daniel Ontaneda
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.